CVA Family Office’s RXO RXO Stock Holding History

CVA Family Office’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24	Closed	-$572	–	1456
2024 Q4	$572	Hold	24	–	–	﹤0.01%	1195
2024 Q3	$672	Hold	24	–	–	﹤0.01%	1132
2024 Q2	$628	Buy	+24	New	+$499	﹤0.01%	1142

Other funds holding RXO

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

CVA Family Office's RXO Position: Q1 2025 in Review

CVA Family Office sold out of RXO (RXO) in Q1 2025, closing a stake of 24 shares — an estimated $572 sold.

CVA Family Office first reported a position in RXO in Q2 2024 and held it in 3 quarters. The position peaked at $672 in Q3 2024. 258 funds tracked by Wall St. Rank hold RXO as of Q1 2025.

CVA Family Office reported no remaining RXO position as of Q1 2025 after selling out during the quarter.
CVA Family Office sold 24 RXO shares in Q1 2025, an estimated $572.
CVA Family Office first reported a position in RXO in Q2 2024 and held it in 3 quarters.
CVA Family Office's RXO position peaked at $672 in Q3 2024.
258 funds tracked by Wall St. Rank held RXO as of Q1 2025.

Based on CVA Family Office's 13F filing for Q1 2025, filed 16 Apr 2025.